When you look at what they have in pre clinical and clinical trials and if results of this research prove fruitfull yes this may well be a $100 plus stock but not forgetting launch of insomnia and ezcema preperations in near future will at least hit 20 to 30 cent mark imo
Ann: June 2017 Quarterly Report, page-25
Add ZLD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.0¢ |
Change
-0.075(9.20%) |
Mkt cap ! $8.510M | |||
| Open | High | Low | Value | Volume |
| 83.0¢ | 83.0¢ | 74.0¢ | $2.138K | 2.835K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 119 | 74.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 773 | 1 |
View Market Depth
| Last trade - 15.43pm 26/09/2024 (20 minute delay) ? |
| ZLD (ASX) Chart |